Trials / Completed
CompletedNCT02554357
Quality of Analgesia After Interscalene Block After Arthroscopic Shoulder Surgery
Quality of Analgesia After Interscalene Block With Bupivacaine and Exparel® vs. Bupivacaine Alone After Arthroscopic Shoulder Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- North American Institute for Continuing Medical Education (NAICE) · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Shoulder arthroscopic causes post operative pain that outlasts analgesia provided by single injection nerve blocks.
Detailed description
The interscalene brachial plexus block (ISBPB) is a common analgesic technique for procedures of the shoulder and upper arm. Moreover, the incidence of rebound pain is well documented and is often of considerable discomfort to patients, who may quickly go from little or no pain to moderate-severe pain. Continuous nerve block techniques with home ambulatory catheters are currently utilized to manage postoperative pain.This study is designed to compare the level and duration of pain control of Exparel® injected after bupivacaine via stop-cock connected syringes and bupivacaine alone for ISBPB.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Exparel block in arthroscopic shoulder surgery | The interscalene block will be performed with ultrasound guidance and nerve stimulation. |
| DRUG | Bupivacaine block in shoulder surgery | The interscalene block will be performed with ultrasound guidance and nerve stimulation. |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2016-01-01
- Completion
- 2016-03-01
- First posted
- 2015-09-18
- Last updated
- 2016-09-08
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02554357. Inclusion in this directory is not an endorsement.